Amedisys (NASDAQ:AMED) Lifted to Buy at StockNews.com

StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report published on Saturday morning. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 target price on shares of Amedisys in […]

Related Keywords

United States ,Canada ,Banque Cantonale Vaudoise ,Raymond James ,Royal Bank ,Cetera Trust Company ,Amedisys Inc ,Amedisys Company Profile ,Amedisys ,Cantor Fitzgerald ,Contravisory Investment Management Inc ,Home Health ,Mesirow Institutional Investment Management Inc ,Free Report ,Get Free Report ,Cantonale Vaudoise ,Investment Management ,Mesirow Institutional Investment Management ,Institutional Investment Management ,High Acuity ,Amedisys Daily ,Nasdaq Amed ,Amed ,Medical ,02343610 ,Upgrade ,Stocknews Com ,